Prince Pharmaceutical Co., Ltd.
6935
Rank in Stocks
#24584
Prince Pharmaceutical Co., Ltd. operates in the production and global sale of... Prince Pharmaceutical Co., Ltd. operates in the production and global sale of active pharmaceutical ingredients (APIs), primarily focusing on vitamin B1. Its market presence extends across Taiwan, Japan, Korea, and other international territories. The company's product portfolio also encompasses a variety of consumer health items and general medicines. These offerings include popular formulations such as vitamin C tablets and vitamin B complex tablets, alongside specialized supplements like natto and rhodiola extract capsules, probiotic sachets, and various plant extract capsules. In addition to vitamin B1, Prince Pharmaceutical supplies a comprehensive array of other APIs, notably felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. The company's distribution network specifically includes countries within Spain and the wider European continent. Established in 1962, Prince Pharmaceutical Co., Ltd. is based in Yunlin County, Taiwan.
Share Price
$0.85661329
Last synced: 2026-11-10
Market Cap
$32.05M
Change (1 day)
4.66%
Change (1 year)
-10.76%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Prince Pharmaceutical Co., Ltd. (6935)
Category
Healthcare
EPS for Prince Pharmaceutical Co., Ltd. (6935)
EPS as of June 2026 TTM: $0.11
According to Prince Pharmaceutical Co., Ltd.'s latest financial reports, its current EPS (TTM) is $0.11. At the end of 2025 the company had an EPS of $0.08, an increase over its 2024 EPS of $-0.04.
EPS history for Prince Pharmaceutical Co., Ltd. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.11 | 36.25% |
| 2025 | $0.08 | -288.31% |
| 2024 | $-0.04 | -417.86% |
| 2023 | $0.01 | -72.28% |
| 2022 | $0.05 | -661.11% |
| 2021 | $-0.01 | -75.48% |
| 2020 | $-0.04 | 0.00% |
| 2019 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 5,864.59% |
DE
|
|
| $6.08 | 5,475.78% |
DE
|
|
| $1.55 | 1,322.57% |
JP
|
|
| $3.66 | 3,257.80% |
CH
|
|
| $0.45 | 312.84% |
IL
|
Questions about Prince Pharmaceutical Co., Ltd.'s earnings per share (EPS)
What is Prince Pharmaceutical Co., Ltd.'s earnings per share (EPS)?
Prince Pharmaceutical Co., Ltd.'s earnings per share (EPS) over the last twelve months is $0.11, as of Jun 2026.
What was Prince Pharmaceutical Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, Prince Pharmaceutical Co., Ltd.'s earnings per share (EPS) was $0.08, compared with $-0.04 in 2024.
How has Prince Pharmaceutical Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Prince Pharmaceutical Co., Ltd.'s earnings per share (EPS) was highest in 2025 ($0.08) and lowest in 2024 ($-0.04).
How does Prince Pharmaceutical Co., Ltd.'s earnings per share (EPS) compare with similar companies?
Prince Pharmaceutical Co., Ltd.'s earnings per share (EPS) ($0.11) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.